Effect of lurasidone on heart function
Part of Heart & circulation, Injuries & trauma, Mental health clinical trials.
This study looks at how lurasidone, a medication for schizophrenia and bipolar disorder, affects the pumping function of the heart's left ventricle. It may help doctors understand if this medicine is safe for your heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old
- You have been diagnosed with schizophrenia or bipolar disorder
- Your doctor has decided to prescribe lurasidone for you
- You do not have coronary artery disease, heart failure, or severe heart valve problems
- You are willing to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding an antipsychotic medicine called lurasidone to your current antidepressant can help reduce depression symptoms. Participants must have tried an antidepressant without enough improvement and continue taking their current antidepressant during the trial.
This study tests the long-term safety of an investigational medication for schizophrenia over one year. It may be an option if you are currently stable on your antipsychotic medication.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This study tests if a medication called lacosamide can help people with bipolar depression that has not improved with at least two other treatments. It's for those with moderate to severe depression in bipolar I or II.
This trial tests whether adding lumateperone, an antipsychotic medication, to clozapine can improve metabolic health in people with schizophrenia. It aims to see if this combination helps with weight, blood sugar, and cholesterol levels.
This study tests a program to improve heart health in people with schizophrenia or bipolar disorder who take antipsychotic medication or lithium and have a high body weight. The goal is to help reduce heart disease risk.
Hear when a new Schizophrenia Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.